Term
|
Definition
alpha 1 blocker Used to treat hypertension and urinary retention. Also decreases PVR |
|
|
Term
|
Definition
Irreversible alpha 1 blocker (also blocks alpha 2 a bit) Used to treat Pheochromocytoma-tumor of adrenal medulla that causes increase release of catecholamine with higher NE:EPI ratio than normal |
|
|
Term
|
Definition
alpha 1a blocker which relieves urinary retention assoc w/ benign prostate hypertrophy by specifically inhibiting contraction of prostate and involuntary sphincter |
|
|
Term
|
Definition
block alpha 1 and alpha 2 equally |
|
|
Term
|
Definition
alpha 2 blocker...little clinical use but used to be for ED but would also raise BP and heart rate. Makes erection by blocking inhibitory alpha-2 receptor on parasympathetic ganglion |
|
|
Term
Alpha 1 blocker Side effects |
|
Definition
reflex tachycardia, postural hypotension, angina, nasal congestion, inhibit ejaculation |
|
|
Term
Propranolol, Timolol, Nadolol |
|
Definition
|
|
Term
Acebutolol, Betaxolol, Esmolol, Atenolol, Metoprolol |
|
Definition
B1 blocker; cardio-specific (only does B2 blocking a little) Treat hypertension and CHF |
|
|
Term
|
Definition
B1/B2 partial agonist means acts as B-blocker when natural agonist is present, but acts as partial agonist otherwise...advantage is it avoids hypoglycemic and bradycardia effects |
|
|
Term
|
Definition
|
|
Term
|
Definition
Chronic Glaucoma (B1 blocks aqueous humor production), hypertension, CHF, reduces MI, angina pain, migraine, hyperthyroidism induced cardiac arrythmias, performance anxiety |
|
|
Term
Beta Blocker Side effects |
|
Definition
Bronchoconstricion-careful with asthmatics Brdycardia-dont give to pts with conduction problems or acute CHF Renin increases bc beta blockers reduce renal flow-this results in increased BP Hypoglycemia from decreased glucagon and gluconeogenesis, careful with diabetics Sexual impairment for men from reduced blood flow |
|
|
Term
|
Definition
a1 antagonist + beta 1 antagonist so decreases PVR without causing reflex tachycardia and w/o altering cardiac output |
|
|